Current pharmaceutical biotechnology2026,Vol.27Issue(5) :542-563,ⅰ.DOI:10.2174/0113892010347680250209183005

Dendrimers-based Hydrogels and Nanogels for Drug Delivery

Deblina D. Bhowmik Juhi S. Gupta Pallavi A. Kamandar Amol D. Gholap Satish Rojekar Navnath T. Hatvate
Current pharmaceutical biotechnology2026,Vol.27Issue(5) :542-563,ⅰ.DOI:10.2174/0113892010347680250209183005

Dendrimers-based Hydrogels and Nanogels for Drug Delivery

Deblina D. Bhowmik 1Juhi S. Gupta 1Pallavi A. Kamandar 1Amol D. Gholap 2Satish Rojekar 3Navnath T. Hatvate1
扫码查看

作者信息

  • 1. Department of Pharmaceutical Technology, Institute of Chemical Technology, Mumbai, Marathwada Campus, Jalna, 431203, India
  • 2. Department of Pharmaceutics, St. John Institute of Pharmacy and Research, Palghar, 401404, Maharashtra, India
  • 3. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • 折叠

Abstract

Current developments in nanotechnology provide an alternative therapy for various diseases by utilizing customized medicine. Among some of the nanoscale superstructures made of the hydrophilic or amphiphilic polymeric matrix are nanogels. At the same time, hydrogels are the first biomaterials created for insertion into the human body and have several biological uses. Owing to the advantages of nanogels and hydrogel, including biocompatibil-ity, hydrophilicity, controlled drug release, and intelligent drug delivery, another macromole-cule called dendrimer is incorporated into the nanogel and hydrogel for synergistic effects. In this review, we focus on the applications of dendrimer-based hydrogels and nanogels as carriers for targeted delivery of drugs. We also present the synthetic processes, different characterization methods, and challenges in incorporating the dendrimer and the drug during the preparation of nanogel and hydrogel. In recent years, the most widely used dendrimers for hydrogel formation have been reported to be poly(amidoamine) (PAMAM), phosphorous, peptide, and polyester dendrimers. Dendrimer-based hydrogel and nanogels show various applications in the treatment of a wide range of diseases, such as glaucoma, cancer, and microbial diseases. The self-cleaving mechanism of dendrimer hydrogels (DH) leads to enhanced and sustained delivery of the drugs in the treatment of cancer. Recent studies show the use of doxorubicin-conjugated nanogel-based PAMAM dendrimer as a capable nanocarrier for the delivery of drugs in the treatment of cancer.

Key words

Dendrimer/hydrogel/drug delivery/gene delivery/PTT/combinational therapy/image-guided drug delivery

引用本文复制引用

出版年

2026
Current pharmaceutical biotechnology

Current pharmaceutical biotechnology

ISSN:1389-2010
段落导航相关论文